Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare CNSX:ATT NYSE:MYI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATTAbattis BioceuticalsC$0.00C$0.05▼C$0.74N/AN/A1.42 million shsN/AMYIBlackRock MuniYield Quality Fund III$10.39+0.0%$10.41$9.98▼$12.07N/A0.57158,075 shs221,442 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATTAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%MYIBlackRock MuniYield Quality Fund III+0.14%+0.73%-2.07%-2.53%-8.58%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/AN/AN/AMYIBlackRock MuniYield Quality Fund IIIN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATTAbattis Bioceuticals 0.00N/AN/AN/AMYIBlackRock MuniYield Quality Fund III 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATTAbattis BioceuticalsN/AN/AN/AN/AN/AN/AMYIBlackRock MuniYield Quality Fund III$11.53MN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATTAbattis BioceuticalsN/AN/A0.00N/AN/AN/AN/AN/AN/AMYIBlackRock MuniYield Quality Fund IIIN/AN/A0.00∞N/AN/AN/AN/A10/1/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthATTAbattis BioceuticalsN/AN/AN/AN/AN/AMYIBlackRock MuniYield Quality Fund III$0.444.24%N/AN/AN/ALatest UEM, ATT, MYI, and WWH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/3/2025MYIBlackRock MuniYield Quality Fund IIImonthly$0.05556.3%7/15/20257/15/20258/1/20256/4/2025MYIBlackRock MuniYield Quality Fund IIImonthly$0.05556.4%6/13/20256/13/20257/1/20255/5/2025MYIBlackRock MuniYield Quality Fund IIImonthly$0.05556.3%5/15/20255/15/20256/2/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATTAbattis BioceuticalsN/AMYIBlackRock MuniYield Quality Fund III34.01%Insider OwnershipCompanyInsider OwnershipATTAbattis BioceuticalsN/AMYIBlackRock MuniYield Quality Fund III1.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATTAbattis BioceuticalsN/AN/AN/ANot OptionableMYIBlackRock MuniYield Quality Fund III147,000N/AN/ANot OptionableOAP3, ATT, N91, and MYI HeadlinesRecent News About These CompaniesMYI BlackRock MuniYield Quality Fund III, Inc. - Seeking AlphaJuly 18, 2025 | seekingalpha.comBlackRock MuniYield Quality Fund III, Inc. (MYI) - Yahoo FinanceJuly 2, 2025 | finance.yahoo.comMYI: An Income Opportunity For Higher Rate TaxpayersMay 5, 2025 | seekingalpha.comSaba Capital Management sells $43,924 in BlackRock Muniyield Pennsylvania Quality Fund sharesJanuary 30, 2025 | msn.com(MYI) Technical Pivots with Risk ControlsJanuary 27, 2025 | news.stocktradersdaily.comNHow to Take Advantage of moves in (MYI)January 16, 2025 | news.stocktradersdaily.comNTrading (MYI) With Integrated Risk ControlsJanuary 6, 2025 | news.stocktradersdaily.comN(MYI) Long Term Investment AnalysisDecember 5, 2024 | news.stocktradersdaily.comNLong Term Trading Analysis for (MYI)November 24, 2024 | news.stocktradersdaily.comNObjective long/short (MYI) ReportNovember 15, 2024 | news.stocktradersdaily.comNBlackRock Investment Quality Municipal Trust Inc. (BKN)September 28, 2024 | finance.yahoo.comWhen (MYI) Moves Investors should ListenSeptember 5, 2024 | news.stocktradersdaily.comNHow the (MYI) price action is used to our AdvantageAugust 14, 2024 | news.stocktradersdaily.comNMYI: Buy The Discount For Rate-Cut RallyJuly 11, 2024 | seekingalpha.comTax Day Blues? These 9%+ Dividends Can Slash Your BillApril 16, 2024 | forbes.comBlackRock MuniYield Fund (MYD)March 14, 2024 | investing.comBlackRock MuniYield Quality Fund III raises dividend by 37%November 16, 2023 | msn.comBLACKROCK MUNIYIELD QUALITY FUND III, INC.'s Dividend AnalysisOctober 13, 2023 | finance.yahoo.comBlackRock S&P 500 Index V.I. Fund IIIAugust 14, 2023 | thestreet.comBlackRock MuniYield Quality Fund III (MYI) Declares $0.04 DividendMay 3, 2023 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesPelosi Makes Big Bet on Broadcom—Here’s Why It MattersBy Gabriel Osorio-Mazilli | July 15, 2025View Pelosi Makes Big Bet on Broadcom—Here’s Why It MattersD-Wave, SuperQ, and Verge: A New Path Forward for Quantum?By Nathan Reiff | July 28, 2025View D-Wave, SuperQ, and Verge: A New Path Forward for Quantum?Tilray Shares Blazing: What's Behind the 55% Rally This Month?By Nathan Reiff | July 14, 2025View Tilray Shares Blazing: What's Behind the 55% Rally This Month?The 4 Dividend Stocks Smart Money Is Grabbing Right NowBy Thomas Hughes | July 24, 2025View The 4 Dividend Stocks Smart Money Is Grabbing Right NowWant Steady Income? 3 Top Dividend Stocks for July 2025By Chris Markoch | July 17, 2025View Want Steady Income? 3 Top Dividend Stocks for July 2025OAP3, ATT, N91, and MYI Company DescriptionsAbattis Bioceuticals CNSX:ATTAbattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.BlackRock MuniYield Quality Fund III NYSE:MYI$10.38 +0.01 (+0.05%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$10.36 -0.03 (-0.28%) As of 08/1/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BlackRock MuniYield Quality Fund III, Inc. is a closed ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC. The fund invests in fixed income markets. It invests primarily in a portfolio of long-term investment-grade municipal obligations exempt from federal income taxes. BlackRock MuniYield Quality Fund III, Inc. was formed in April 13, 1992 and is domiciled in United States. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale Is PG&E an AI Power Play? Why Options Traders Are Betting Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
